Jim Simons Summit Therapeutics Inc. Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.68 - $5.31 $15,844 - $123,722	23,300 New	23,300 $99,000
Q2 2022 Aug 12, 2022	BUY	$0.92 - $2.38 $45,188 - $116,900	49,118 New	49,118 $49,000
Q3 2021 Nov 12, 2021	SELL	$4.83 - $8.27 $605,933 - $1.04 Million	-125,452 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$5.15 - $8.46 $292,726 - $480,866	56,840 Added 82.84%	125,452 $936,000
Q1 2021 May 13, 2021	SELL	$5.17 - $11.19 $954,382 - $2.07 Million	-184,600 Reduced 72.9%	68,612 $403,000
Q4 2020 Feb 10, 2021	SELL	$3.25 - $6.0 $163,150 - $301,200	-50,200 Reduced 16.55%	253,212 $1.19 Million
Q3 2020 Nov 13, 2020	BUY	$3.08 - $3.8 $934,508 - $1.15 Million	303,412 New	303,412 $1.04 Million

192

75.8M

2.01M

2.84M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.59B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.